4/21
01:07 pm
orka
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Globe and Mail, The (Toronto, Canada)]
Low
Report
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Globe and Mail, The (Toronto, Canada)]
4/21
12:57 pm
orka
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Yahoo! Finance]
Low
Report
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Yahoo! Finance]
4/16
08:03 am
orka
Oruka Therapeutics price target raised to $85 from $45 at Wedbush [Yahoo! Finance]
Low
Report
Oruka Therapeutics price target raised to $85 from $45 at Wedbush [Yahoo! Finance]
4/15
08:41 am
orka
Oruka Therapeutics (ORKA) had its price target raised by Wedbush from $45.00 to $85.00. They now have an "outperform" rating on the stock.
Medium
Report
Oruka Therapeutics (ORKA) had its price target raised by Wedbush from $45.00 to $85.00. They now have an "outperform" rating on the stock.
4/13
10:22 am
orka
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by Guggenheim. They now have a $125.00 price target on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by Guggenheim. They now have a $125.00 price target on the stock.
4/13
08:00 am
orka
Oruka Therapeutics (ORKA) had its price target raised by BTIG Research from $73.00 to $78.00. They now have a "buy" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by BTIG Research from $73.00 to $78.00. They now have a "buy" rating on the stock.
4/13
08:00 am
orka
Oruka Therapeutics (ORKA) had its price target raised by HC Wainwright from $40.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by HC Wainwright from $40.00 to $70.00. They now have a "buy" rating on the stock.
4/7
02:33 pm
orka
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $50.00 to $78.00. They now have an "overweight" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $50.00 to $78.00. They now have an "overweight" rating on the stock.
4/6
03:21 pm
orka
Oruka Therapeutics (ORKA) had its price target raised by UBS Group AG from $50.00 to $75.00. They now have a "buy" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by UBS Group AG from $50.00 to $75.00. They now have a "buy" rating on the stock.
4/6
08:02 am
orka
Oruka Therapeutics (ORKA) had its price target raised by Guggenheim from $60.00 to $125.00. They now have a "buy" rating on the stock.
Medium
Report
Oruka Therapeutics (ORKA) had its price target raised by Guggenheim from $60.00 to $125.00. They now have a "buy" rating on the stock.
3/16
03:21 pm
orka
Oruka Therapeutics (ORKA) had its price target raised by Leerink Partners from $58.00 to $86.00. They now have an "outperform" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by Leerink Partners from $58.00 to $86.00. They now have an "outperform" rating on the stock.
3/16
01:09 am
orka
Medium
Report
3/13
03:58 pm
orka
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $48.00 to $50.00. They now have an "overweight" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $48.00 to $50.00. They now have an "overweight" rating on the stock.
3/13
10:59 am
orka
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by BTIG Research. They now have a $73.00 price target on the stock.
Medium
Report
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by BTIG Research. They now have a $73.00 price target on the stock.
3/13
10:40 am
orka
Oruka Therapeutics (ORKA) had its price target raised by Stifel Nicolaus from $47.00 to $72.00. They now have a "buy" rating on the stock.
Medium
Report
Oruka Therapeutics (ORKA) had its price target raised by Stifel Nicolaus from $47.00 to $72.00. They now have a "buy" rating on the stock.
3/12
04:42 pm
orka
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/12
04:05 pm
orka
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
High
Report
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
3/8
01:31 am
orka
Low
Report
2/9
08:06 am
orka
Oruka Therapeutics to Participate in Multiple Upcoming Conferences [Yahoo! Finance]
Low
Report
Oruka Therapeutics to Participate in Multiple Upcoming Conferences [Yahoo! Finance]
2/9
07:00 am
orka
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
Low
Report
Oruka Therapeutics to Participate in Multiple Upcoming Conferences